GoodRx Holdings, Inc. (GDRX) vs Tyra Biosciences, Inc. (TYRA)

A side-by-side comparison of GoodRx Holdings, Inc. and Tyra Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GDRX vs TYRA

growth of $100 · dividends reinvested · last 5y
GDRX -92.4% (-40.3%/yr)TYRA -19.5% (-4.2%/yr)TYRA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$8$81
GDRX TYRA

GDRX vs TYRA: by the numbers

  • •TYRA is the larger company ($1.21B vs $1.13B market cap).
  • •GDRX is profitable (2.07% net margin) while TYRA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricGDRXTYRA
P/E ratio76.94N/A
P/S ratio1.44N/A
P/B ratio1.753.41
EV / EBITDA8.14N/A
FCF yield12.86%N/A

Profitability

MetricGDRXTYRA
Gross margin88.05%0.00%
Operating margin10.25%0.00%
Net margin2.07%0.00%
ROE2.51%-42.01%
ROIC3.72%-44.73%

Growth (annualized)

MetricGDRXTYRA
Revenue CAGR (5Y)4.47%N/A
FCF CAGR (5Y)11.72%N/A
Total return CAGR (5Y)-39.98%9.23%

Frequently asked

Is GDRX or TYRA more profitable?
GDRX runs the higher net margin — GDRX at 2.07% versus TYRA at 0.00%.
How have GDRX and TYRA total returns compared?
Over the past 5 years, GDRX delivered -39.98% and TYRA delivered 9.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.